MANILA, Philippines — The Food and Drug Administration (FDA) is asking for the help of the Russian embassy in the country so the agency can expedite the granting of an emergency use authorization (EUA) for the Sputnik-V Covid-19 vaccine of the Gamaleya Institute.
During the online meeting of the House committee on people’s participation on Thursday, FDA Director-General Eric Domingo said Gamaleya’s EUA application for Sputnik-V remains pending in the Philippines. The said vaccine already has a EUA issued from countries such as Russia and Argentina.
Domingo said the Russian embassy can provide an authorization letter that will assure the FDA that Gamaleya’s local rep…
Keep on reading: FDA asks for Russian embassy help to expedite EUA for Sputnik-V vaccine